Search - tctmd.com

Displaying 61 - 80 of 130

Sort: Relevancy | Date

News Conference News EuroPCR 2017

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

Caitlin E. Cox

May 22, 2017

Presentation EuroPCR 2017

First Report of a 2.0 mm ZotarolimusEluting Stent for the Treatment of Very Small Coronary Vessels

Presenter: Matthew J. Price

May 19, 2017

News Conference News EuroPCR 2017

Slimmest Stent to Date Looks Promising in Small Study

Shelley Wood

May 19, 2017

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

News Conference News EuroPCR 2017

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Michael O'Riordan

May 19, 2017

Presentation EuroPCR 2017

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Presenter: Bernando Cortese

May 19, 2017

Presentation EuroPCR 2017

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Presenter: Roberto Diletti

May 18, 2017

News Conference News EuroPCR 2017

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

Michael O'Riordan

May 18, 2017

News Conference News EuroPCR 2017

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

Caitlin E. Cox

May 18, 2017

News Conference News EuroPCR 2017

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

Michael O'Riordan

May 18, 2017

Presentation EuroPCR 2017

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Presenter: Ken Kozuma

May 17, 2017

Presentation EuroPCR 2017

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

Presenter: Runlin Gao

May 17, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Michael O'Riordan

May 16, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

News Conference News EuroPCR 2016

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Shelley Wood

May 18, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Advertisement

Best Antiplatelet Therapy in Real-World PCI? European Registries Fuel the Debate

First Report of a 2.0 mm ZotarolimusEluting Stent for the Treatment of Very Small Coronary Vessels

Slimmest Stent to Date Looks Promising in Small Study

BIO-RESORT Silent Diabetes

Scaffold Thrombosis ‘Unpredictable’ With Absorb: AIDA Analysis

Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management

Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention The FFR-SEARCH Study

Transradial PCI in ACS Reduces Risk of Acute Kidney Injury

FFR-SEARCH Explores Potential of Physiologic Assessment After PCI

BIO-RESORT: Impaired Glucose Metabolism Linked With Worse Clinical Outcomes After PCI

ABSORB Japan Results: 3-year Clinical and Angiographic Results

Randomized Comparison of Everolimus-eluting Bioresorbable Vascular Scaffolds vs. Everolimus-eluting Metallic Stents in Patients with Coronary Artery Disease: 3-year Clinical Outcomes from ABSORB China

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Stent ‘Sealing’ of Nonobstructive Saphenous Vein Graft Plaques Fails to Prevent CV Events

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content